$MNDR
Mobile-health Network Solutions Stock $mndr

$mndr Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 20-F Financial Statement

#000149315224042243 Filed on October 23, 2024

Income Statement

Concept	2024 Q2	2024	2023 Q2
Revenue	$13.97M	$13.97M	$7.875M
YoY Change	77.38%	77.38%
Cost Of Revenue	$11.43M	$11.43M	$6.780M
YoY Change	68.59%	68.59%
Gross Profit	$2.538M	$2.538M	$1.095M
YoY Change	131.82%	131.81%
Gross Profit Margin	18.17%	18.17%	13.9%
Selling, General & Admin	$18.09M	$4.928M	$4.289M
YoY Change	321.86%	14.89%
% of Gross Profit	712.78%	194.12%	391.68%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$96.96K	$149.1K	$50.03K
YoY Change	93.81%	57.22%	-42.55%
% of Gross Profit	3.82%	5.87%	4.57%
Operating Expenses	$18.24M	$18.24M	$4.384M
YoY Change	316.14%	316.14%
Operating Profit	-$15.70M	-$15.70M	-$3.289M
YoY Change	377.51%	377.51%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$81.76K	$81.76K	$75.34K
YoY Change	8.52%	8.52%
Pretax Income	-$15.62M	-$15.62M	-$3.213M
YoY Change	386.16%	386.16%
Income Tax	-$19.19K	-$19.19K	$0.00
% Of Pretax Income
Net Earnings	-$15.60M	-$15.60M	-$3.213M
YoY Change	385.56%	385.56%
Net Earnings / Revenue	-111.7%	-111.7%	-40.81%
Basic Earnings Per Share		-$0.56
Diluted Earnings Per Share	-$0.56	-$0.56	-$0.09
COMMON SHARES
Basic Shares Outstanding		27.81M shares
Diluted Shares Outstanding		27.81M shares

Balance Sheet

Concept	2024 Q2	2024	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.708M	$6.708M	$2.226M
YoY Change	201.36%	201.36%
Cash & Equivalents	$6.708M	$6.708M	$2.226M
Short-Term Investments
Other Short-Term Assets	$222.7K	$222.7K	$164.4K
YoY Change	35.48%	35.48%
Inventory	$164.0K	$164.0K	$146.4K
Prepaid Expenses	$108.2K		$38.76K
Receivables	$111.1K	$194.6K	$181.2K
Other Receivables	$83.56K	$0.00	$0.00
Total Short-Term Assets	$7.289M	$7.289M	$2.718M
YoY Change	168.2%	168.2%
LONG-TERM ASSETS
Property, Plant & Equipment	$216.0K	$586.7K	$572.0K
YoY Change	-62.23%	2.56%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments			$0.00
YoY Change
Other Assets	$55.96K	$55.96K	$81.95K
YoY Change	-31.72%	-31.71%
Total Long-Term Assets	$661.6K	$661.6K	$724.7K
YoY Change	-8.72%	-8.71%
TOTAL ASSETS
Total Short-Term Assets	$7.289M	$7.289M	$2.718M
Total Long-Term Assets	$661.6K	$661.6K	$724.7K
Total Assets	$7.951M	$7.951M	$3.443M
YoY Change	130.95%	130.95%	-67.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.671M	$1.671M	$1.359M
YoY Change	22.99%	22.99%
Accrued Expenses	$1.318M	$1.318M	$980.8K
YoY Change	34.4%	34.4%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$3.158M	$3.158M	$2.500M
YoY Change	26.33%	26.33%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$652.9K	$652.9K	$1.310M
YoY Change	-50.15%	-50.15%
Total Long-Term Liabilities	$652.9K	$652.9K	$1.310M
YoY Change	-50.15%	-50.15%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.158M	$3.158M	$2.500M
Total Long-Term Liabilities	$652.9K	$652.9K	$1.310M
Total Liabilities	$3.811M	$3.811M	$3.810M
YoY Change	0.04%	0.04%
SHAREHOLDERS EQUITY
Retained Earnings	-$24.76M		-$9.153M
YoY Change	170.47%
Common Stock	$28.47M		$8.497M
YoY Change	235.03%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.139M	$4.139M	-$367.2K
YoY Change
Total Liabilities & Shareholders Equity	$7.951M	$7.951M	$3.443M
YoY Change	130.95%	130.95%

Cashflow Statement

Concept	2024 Q2	2024	2023 Q2
OPERATING ACTIVITIES
Net Income	-$15.60M	-$15.60M	-$3.213M
YoY Change	385.56%	385.56%
Depreciation, Depletion And Amortization	$96.96K	$149.1K	$50.03K
YoY Change	93.81%	57.22%	-42.55%
Cash From Operating Activities		-$6.405M	-$1.546M
YoY Change		184.86%	-258.41%
INVESTING ACTIVITIES
Capital Expenditures		$134.2K	$60.74K
YoY Change		-27.84%	299.34%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$134.2K	-$60.74K
YoY Change		-27.84%	299.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		-$10.85M	-$5.755M
YoY Change		88.53%	-159.28%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$10.88M	-5.924M
YoY Change		-287.61%	-164.15%
NET CHANGE
Cash From Operating Activities		-$6.405M	-1.546M
Cash From Investing Activities		-$134.2K	-60.74K
Cash From Financing Activities		$10.88M	-5.924M
Net Change In Cash		$4.482M	-7.530M
YoY Change		-154.42%	-173.87%
FREE CASH FLOW
Cash From Operating Activities		-$6.405M	-$1.546M
Capital Expenditures		$134.2K	$60.74K
Free Cash Flow		-$6.540M	-$1.606M
YoY Change		168.61%	-267.24%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001976695
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024	MNDR	Government Incentives GovernmentIncentives		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses		usd
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses		usd
CY2024	MNDR	Reversal Provision For Stock Obsolesces ReversalProvisionForStockObsolesces		usd
CY2022	MNDR	Reversal Provision For Stock Obsolesces ReversalProvisionForStockObsolesces		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable		usd
CY2024	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
CY2024	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2024	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	MNDR	Cash Refund From Income Taxes CashRefundFromIncomeTaxes		usd
CY2024	MNDR	Shares Issued Via Capitalization Of Amount Due To Director SharesIssuedViaCapitalizationOfAmountDueToDirector		usd
CY2023	MNDR	Shares Issued Via Capitalization Of Amount Due To Director SharesIssuedViaCapitalizationOfAmountDueToDirector		usd
CY2024	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease		usd
CY2024	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses		usd
CY2024	MNDR	Reversal Provision For Stock Obsolesces ReversalProvisionForStockObsolesces		usd
CY2024Q2	MNDR	Accrued Director Current AccruedDirectorCurrent		usd
CY2024Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		usd
CY2024	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards		usd
CY2024Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance		usd
CY2024Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2024	dei	Document Type DocumentType	20-F
CY2024	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2024	dei	Entity File Number EntityFileNumber	001-41990
CY2024	dei	Entity Registrant Name EntityRegistrantName	Mobile-health Network Solutions
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	2 Venture Drive
CY2024	dei	Entity Address Address Line2 EntityAddressAddressLine2	#07-06/07 Vision Exchange
CY2024	dei	Entity Address Country EntityAddressCountry	SG
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	608526
CY2024	dei	Security12b Title Security12bTitle	Class A Ordinary Shares
CY2024	dei	Trading Symbol TradingSymbol	MNDR
CY2024	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024	dei	Auditor Name AuditorName	JWF Assurance PAC
CY2024	dei	Auditor Location AuditorLocation	Singapore
CY2024	dei	Auditor Firm AuditorFirmId	7095
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6707695	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2225806	usd
CY2024Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	111066	usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	74315	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	163993	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	146381	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	222737	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	164410	usd
CY2024Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	83563	usd
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	106897	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	7289054	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	2717809	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	216047	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	178799	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18952	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	70783	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	370607	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	393198	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55955	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	81950	usd
CY2024Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	661561	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	724730	usd
CY2024Q2	us-gaap	Assets Assets	7950615	usd
CY2023Q2	us-gaap	Assets Assets	3442539	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1671201	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	1358816	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1078094	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	826167	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	240090	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154604	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3158296	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	2500088	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	135920	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	241179	usd
CY2024Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	652866	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1309650	usd
CY2024Q2	us-gaap	Liabilities Liabilities	3811162	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3809738	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28466888	usd
CY2023Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	8496710	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24755793	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-9153001	usd
CY2024Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	428220	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	288990	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	4139453	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-367199	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7950615	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3442539	usd
CY2024	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13968535	usd
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7874886	usd
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6988849	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	11430162	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	6779892	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	5053743	usd
CY2024	us-gaap	Gross Profit GrossProfit	2538373	usd
CY2023	us-gaap	Gross Profit GrossProfit	1094994	usd
CY2022	us-gaap	Gross Profit GrossProfit	1935106	usd
CY2024	us-gaap	Salaries And Wages SalariesAndWages	4045692	usd
CY2023	us-gaap	Salaries And Wages SalariesAndWages	2389892	usd
CY2022	us-gaap	Salaries And Wages SalariesAndWages	1038877	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149078	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	94816	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	87094	usd
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	4927584	usd
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1898986	usd
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	615473	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	9119764	usd
CY2024	us-gaap	Operating Expenses OperatingExpenses	18242118	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4383694	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	1741444	usd
CY2023	MNDR	Government Incentives GovernmentIncentives	27892	usd
CY2022	MNDR	Government Incentives GovernmentIncentives	2357	usd
CY2024	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	81759	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	47448	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	62453	usd
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	81759	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	75340	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	64810	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15621986	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3213360	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258472	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19194	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	165775	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15602792	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3213360	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	92697	usd
CY2024	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	139230	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	396262	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-114433	usd
CY2024	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15463562	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2817098	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21736	usd
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.56
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.56
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.13
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	27808375	shares
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	27808375	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25482000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25482000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21600500	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21600500	shares
CY2021Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-6025096	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14482961	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	92697	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	-114433	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8436129	usd
CY2023	MNDR	Stock Issued During Period Ordinary Shares Buy Back StockIssuedDuringPeriodOrdinarySharesBuyBack	-6848273	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	862043	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3213360	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	396262	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-367199	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-367199	usd
CY2024	MNDR	Stock Issued During Period Value Private Placement Exercise StockIssuedDuringPeriodValuePrivatePlacementExercise	1724073	usd
CY2024	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9119764	usd
CY2024	MNDR	Stock Issued During Period Value Public Offering Exercise StockIssuedDuringPeriodValuePublicOfferingExercise	9126376	usd
CY2024	MNDR	Stock Issued During Period Value Cashless Exercise Of Common Stock Warrants StockIssuedDuringPeriodValueCashlessExerciseOfCommonStockWarrants	1	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15602792	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15602792	usd
CY2024	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent	139230	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4139453	usd
CY2024Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4139453	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15602792	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3213360	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	92697	usd
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	149078	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	94816	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	87094	usd
CY2024	MNDR	Non Cash Lease Expenses NonCashLeaseExpenses	184820	usd
CY2023	MNDR	Non Cash Lease Expenses NonCashLeaseExpenses	106076	usd
CY2022	MNDR	Non Cash Lease Expenses NonCashLeaseExpenses	49696	usd
CY2023	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	-2887	usd
CY2022	us-gaap	Gain Loss On Disposition Of Intangible Assets GainLossOnDispositionOfIntangibleAssets	8958	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	549	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	106450	usd
CY2023	MNDR	Reversal Provision For Stock Obsolesces ReversalProvisionForStockObsolesces	20438	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	9119764	usd
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	36751	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	513	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-119360	usd
CY2024	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	32332	usd
CY2023	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	210622	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	2287	usd
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	17612	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	92813	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-22065	usd
CY2024	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	312385	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	748515	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	298587	usd
CY2024	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	-299924	usd
CY2023	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	431812	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	229844	usd
CY2024	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-182002	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-105212	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-47353	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-137100	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	134362	usd
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6405366	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2248626	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	975656	usd
CY2024	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	134211	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	186001	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	15211	usd
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-134211	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-186001	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-15211	usd
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10850450	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	843081	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	9709166	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6598240	usd
CY2024	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	31786	usd
CY2023	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-45293	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-11889	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	463381	usd
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10882236	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5800452	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9233896	usd
CY2024	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	139230	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	217797	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-114433	usd
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4481889	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8017282	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10079908	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2225806	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10243088	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	163180	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	6707695	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2225806	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10243088	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	217228	usd
CY2024	MNDR	Cash Refund From Income Taxes CashRefundFromIncomeTaxes	71532	usd
CY2023	MNDR	Cash Refund From Income Taxes CashRefundFromIncomeTaxes	27844	usd
CY2022	MNDR	Shares Issued Via Capitalization Of Amount Due To Director SharesIssuedViaCapitalizationOfAmountDueToDirector	4773795	usd
CY2024	MNDR	Investment Description Of Principal Activities InvestmentDescriptionOfPrincipalActivities	Investment holding
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_843_eus-gaap--UseOfEstimates_zV6gVdzerjZ9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_z6zJvQLvstak">Use of estimates</span> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make judgements, estimates and assumptions that affect the application of policies and reported amounts of assets, liabilities, income and expenses. The estimates and associated assumptions are based on historical experience and various other factors that are believed to be reasonable under the circumstances, the results of which form the basis of making the judgements about carrying values of assets and liabilities that are not readily apparent from other sources. Significant accounting estimates reflected in the Company’s consolidated financial statements include, but are not limited to, inventory valuation, impairment of long-lived assets, estimated useful life of property and equipment and intangible assets, and allowance for credit losses on receivables, and realisation of deferred tax assets. Actual results may differ from these estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
CY2024	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	0	usd
CY2024	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	integer
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_z3TdAZ3WyORf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zVmJMrDvJbDh">Concentrations and credit risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains its cash balances with banks in the Republic of Singapore. Should any bank holding cash become insolvent, or if the Company is otherwise unable to withdraw funds, the Company would lose the cash with that bank; however, the Company has not experienced any losses in such accounts and believes it is not exposed to any significant risks on its cash in bank accounts. In Singapore, a depositor has up to S$<span id="xdx_909_eus-gaap--CashFDICInsuredAmount_iI_c20240630_zX2y7Lxxkls3" title="Cash SDIC insured amount">75,000</span> insured by Singapore Deposit Insurance Corporation (“SDIC”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024 and 2023, $<span id="xdx_90E_eus-gaap--CashUninsuredAmount_iI_c20240630_zqgOEIdz1s74" title="Cash uninsured amount">1,367,708</span> and $<span id="xdx_900_eus-gaap--CashUninsuredAmount_iI_c20230630_zYKnhDZEFmR6" title="Cash uninsured amount">1,921,497</span> of the company’s cash held by financial institutions were uninsured respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially expose the Company to concentration of credit risk consist primarily of cash and cash equivalent and accounts receivable. The Company has designed its credit policies with an objective to minimize their exposure to credit risk. The Company’s accounts receivable are short term in nature and the associated risk is minimal. The Company conducts credit evaluations on its clients and generally does not require collateral or other security. The Company periodically evaluates the creditworthiness of the existing clients in determining the allowance for doubtful accounts primarily based upon the age of the receivables and factors surrounding the credit risk of specific clients. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended June 30, 2024 and 2023, none of the customers accounted more than 10% of the Company’s total sales.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024, none of the customers amounted more than 10% of the Company’s account receivables. Customer A accounted <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20230701__20240630__srt--MajorCustomersAxis__custom--CustomerAMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zasSGNSykuT9" title="Concentration risk, percentage">21</span>% of the account receivables as of June 30, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended June 30, 2024 and 2023, none of the suppliers accounted more than 10% of the Company’s total purchases.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of June 30, 2024 and 2023, none of the suppliers accounted more than 10% of the account payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q2	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	75000	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1367708	usd
CY2023Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1921497	usd
CY2024	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2023	us-gaap	Dilutive Securities DilutiveSecurities	0	usd
CY2024Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	232844	usd
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	196345	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	121778	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	122030	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111066	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	74315	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	122030	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	14540	usd
CY2023	us-gaap	Allowance For Doubtful Accounts Receivable Period Increase Decrease AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease	106450	usd
CY2024	MNDR	Allowance For Doubtful Accounts Receivable Exchange Difference AllowanceForDoubtfulAccountsReceivableExchangeDifference	-252	usd
CY2023	MNDR	Allowance For Doubtful Accounts Receivable Exchange Difference AllowanceForDoubtfulAccountsReceivableExchangeDifference	1040	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	121778	usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	122030	usd
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	106450	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	188274	usd
CY2023Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	170712	usd
CY2024Q2	MNDR	Allowance For Stock Obsolescence AllowanceForStockObsolescence	24281	usd
CY2023Q2	MNDR	Allowance For Stock Obsolescence AllowanceForStockObsolescence	24331	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	163993	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	146381	usd
CY2023Q2	MNDR	Allowance For Stock Obsolescence AllowanceForStockObsolescence	24331	usd
CY2022Q2	MNDR	Allowance For Stock Obsolescence AllowanceForStockObsolescence	3669	usd
CY2023	MNDR	Reversal Provision For Stock Obsolesces ReversalProvisionForStockObsolesces	20438	usd
CY2024	MNDR	Allowance For Stock Obsolescence Exchange Difference AllowanceForStockObsolescenceExchangeDifference	-50	usd
CY2023	MNDR	Allowance For Stock Obsolescence Exchange Difference AllowanceForStockObsolescenceExchangeDifference	224	usd
CY2024Q2	MNDR	Allowance For Stock Obsolescence AllowanceForStockObsolescence	24281	usd
CY2023Q2	MNDR	Allowance For Stock Obsolescence AllowanceForStockObsolescence	24331	usd
CY2024Q2	MNDR	Inventories Pledged As Security InventoriesPledgedAsSecurity	0	usd
CY2023Q2	MNDR	Inventories Pledged As Security InventoriesPledgedAsSecurity	0	usd
CY2024Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	63067	usd
CY2023Q2	us-gaap	Deposits Assets Current DepositsAssetsCurrent	47170	usd
CY2024Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	108207	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	38758	usd
CY2024Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	51463	usd
CY2023Q2	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	78482	usd
CY2024Q2	us-gaap	Other Assets Current OtherAssetsCurrent	222737	usd
CY2023Q2	us-gaap	Other Assets Current OtherAssetsCurrent	164410	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	55955	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	81950	usd
CY2024Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	84985	usd
CY2023Q2	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	65725	usd
CY2024Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	19070	usd
CY2023Q2	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	19109	usd
CY2024Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	66371	usd
CY2023Q2	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	39621	usd
CY2024Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	316849	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	231820	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	487275	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	356275	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	271228	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	177476	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	216047	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	178799	usd
CY2024Q2	us-gaap	Depreciation Depreciation	96963	usd
CY2023Q2	us-gaap	Depreciation Depreciation	43339	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	682589	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	683999	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	663637	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	613216	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18952	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	70783	usd
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	52115	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	51477	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6508	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6508	usd
CY2024Q2	MNDR	Finite Lived Intangible Assets Amortization Expense After Year Two FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearTwo	5936	usd
CY2024Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	18952	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	370607	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	393198	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	240090	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	154604	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	135920	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	241179	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	376010	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	395783	usd
CY2024	us-gaap	Operating Lease Cost OperatingLeaseCost	195674	usd
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	112202	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	247832	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	137443	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	385275	usd
CY2024Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9265	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	376010	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	240090	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	135920	usd
CY2024Q2	MNDR	Accrued Staff Salaries Current AccruedStaffSalariesCurrent	584932	usd
CY2023Q2	MNDR	Accrued Staff Salaries Current AccruedStaffSalariesCurrent	95480	usd
CY2023Q2	MNDR	Accrued Director Current AccruedDirectorCurrent	44258	usd
CY2024Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	207769	usd
CY2023Q2	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	503286	usd
CY2023Q2	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	11761	usd
CY2024Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	285393	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	171382	usd
CY2024Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1078094	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	826167	usd
CY2024	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	50000	usd
CY2024Q2	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	0	shares
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13968535	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7874886	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6988849	usd
CY2024	us-gaap	Cost Of Revenue CostOfRevenue	11430162	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	6779892	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	5053743	usd
CY2024	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13968535	usd
CY2024	us-gaap	Gross Profit GrossProfit	2538373	usd
CY2024	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-15621986	usd
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-15602792	usd
CY2024Q2	us-gaap	Assets Assets	7950615	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7874886	usd
CY2023	us-gaap	Gross Profit GrossProfit	1094994	usd
CY2023	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	-3213360	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3213360	usd
CY2023Q2	us-gaap	Assets Assets	3442539	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6988849	usd
CY2022	us-gaap	Gross Profit GrossProfit	1935106	usd
CY2022	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	258472	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	92697	usd
CY2022Q2	us-gaap	Assets Assets	10755624	usd
CY2024	MNDR	Effective Income Tax Rate Reconciliation First Taxable Income EffectiveIncomeTaxRateReconciliationFirstTaxableIncome	0.75	pure
CY2024	MNDR	Effective Income Tax Rate Reconciliation First Taxable Income Value EffectiveIncomeTaxRateReconciliationFirstTaxableIncomeValue	10000	sgd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Tax Exempt Income EffectiveIncomeTaxRateReconciliationTaxExemptIncome	0.50	pure
CY2024	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	190000	sgd
CY2024	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-19194	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	165226	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	549	usd
CY2024	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-19194	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	165775	usd
CY2024	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-15621986	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3213360	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	258472	usd
CY2024	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.170	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.170	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	-0.170	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.222	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.047	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense EffectiveIncomeTaxRateReconciliationNondeductibleExpense	0.228	pure
CY2024	MNDR	Effective Income Tax Rate Reconciliation Income Not Subject To Tax EffectiveIncomeTaxRateReconciliationIncomeNotSubjectToTax	-0.001	pure
CY2023	MNDR	Effective Income Tax Rate Reconciliation Income Not Subject To Tax EffectiveIncomeTaxRateReconciliationIncomeNotSubjectToTax	-0.003	pure
CY2022	MNDR	Effective Income Tax Rate Reconciliation Income Not Subject To Tax EffectiveIncomeTaxRateReconciliationIncomeNotSubjectToTax	-0.065	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.088	pure
CY2024	MNDR	Effective Income Tax Rate Reconciliation Utilization Of Previously Unrecognized Tax Losses EffectiveIncomeTaxRateReconciliationUtilizationOfPreviouslyUnrecognizedTaxLosses	0.000	pure
CY2023	MNDR	Effective Income Tax Rate Reconciliation Utilization Of Previously Unrecognized Tax Losses EffectiveIncomeTaxRateReconciliationUtilizationOfPreviouslyUnrecognizedTaxLosses	0.000	pure
CY2022	MNDR	Effective Income Tax Rate Reconciliation Utilization Of Previously Unrecognized Tax Losses EffectiveIncomeTaxRateReconciliationUtilizationOfPreviouslyUnrecognizedTaxLosses	-0.175	pure
CY2024	MNDR	Effective Income Tax Rate Reconciliation Deferred Tax Assets Not Recognised EffectiveIncomeTaxRateReconciliationDeferredTaxAssetsNotRecognised	-0.051	pure
CY2023	MNDR	Effective Income Tax Rate Reconciliation Deferred Tax Assets Not Recognised EffectiveIncomeTaxRateReconciliationDeferredTaxAssetsNotRecognised	0.126	pure
CY2022	MNDR	Effective Income Tax Rate Reconciliation Deferred Tax Assets Not Recognised EffectiveIncomeTaxRateReconciliationDeferredTaxAssetsNotRecognised	0.393	pure
CY2024	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Reconciling Items Percent EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent	0.002	pure
CY2024	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.000	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.641	pure
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	406251	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	406251	usd
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	9119764	usd
CY2024Q2	us-gaap	Share Price SharePrice	1.74
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	0.004
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.6180	pure
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0450	pure
CY2024	us-gaap	Lease Cost LeaseCost	21000	usd

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-24-042243-index-headers.html	Edgar Link	pending
0001493152-24-042243-index.html	Edgar Link	pending
0001493152-24-042243.txt	Edgar Link	pending
0001493152-24-042243-xbrl.zip	Edgar Link	pending
ex12-1.htm	Edgar Link	pending
ex12-2.htm	Edgar Link	pending
ex13-1.htm	Edgar Link	pending
ex13-2.htm	Edgar Link	pending
ex19-1.htm	Edgar Link	pending
ex21-1.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
ex23-1_002.jpg	Edgar Link	pending
ex23-2.htm	Edgar Link	pending
ex23-2_001.jpg	Edgar Link	pending
ex23-2_002.jpg	Edgar Link	pending
ex97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form20-f.htm	Edgar Link	pending
form20f_001.jpg	Edgar Link	pending
form20f_002.jpg	Edgar Link	pending
form20f_003.jpg	Edgar Link	pending
form20f_004.jpg	Edgar Link	pending
form20f_005.jpg	Edgar Link	pending
form20f_006.jpg	Edgar Link	pending
form20f_007.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mndr-20240630.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
mndr-20240630_cal.xml	Edgar Link	unprocessable
mndr-20240630_lab.xml	Edgar Link	unprocessable
mndr-20240630_pre.xml	Edgar Link	unprocessable
form20-f_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
mndr-20240630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNDR
Mobile-health Network Solutions Stock $mndr

2024 Q2 Form 20-F Financial Statement

#000149315224042243 Filed on October 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNDR Mobile-health Network Solutions Stock $mndr

2024 Q2 Form 20-F Financial Statement

#000149315224042243 Filed on October 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNDR
Mobile-health Network Solutions Stock $mndr